Morgan Stanley’s Sharps Compliance Corp SMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-452,957
| Closed | -$1.32M | – | 8156 |
|
|
2022
Q2 | $1.32M | Buy |
452,957
+112,460
| +33% | +$469K | ﹤0.01% | 4831 |
|
|
2022
Q1 | $2.01M | Sell |
340,497
-31,306
| -8% | -$197K | ﹤0.01% | 4527 |
|
|
2021
Q4 | $2.65M | Sell |
371,803
-159,832
| -30% | -$1.23M | ﹤0.01% | 4348 |
|
|
2021
Q3 | $4.4M | Sell |
531,635
-71,779
| -12% | -$668K | ﹤0.01% | 3869 |
|
|
2021
Q2 | $6.21M | Buy |
603,414
+428,350
| +245% | +$5.96M | ﹤0.01% | 3553 |
|
|
2021
Q1 | $2.52M | Buy |
175,064
+33,114
| +23% | +$426K | ﹤0.01% | 4092 |
|
|
2020
Q4 | $1.34M | Buy |
141,950
+382
| +0.3% | +$2.92K | ﹤0.01% | 4474 |
|
|
2020
Q3 | $887K | Sell |
141,568
-912
| -0.6% | -$6.63K | ﹤0.01% | 4298 |
|
|
2020
Q2 | $1M | Sell |
142,480
-63,694
| -31% | -$453K | ﹤0.01% | 4168 |
|
|
2020
Q1 | $1.64M | Sell |
206,174
-14,017
| -6% | -$72.2K | ﹤0.01% | 3538 |
|
|
2019
Q4 | $929K | Buy |
220,191
+20,892
| +10% | +$89.7K | ﹤0.01% | 4585 |
|
|
2019
Q3 | $827K | Buy |
199,299
+10,600
| +6% | +$40.1K | ﹤0.01% | 4409 |
|
|
2019
Q2 | $672K | Buy |
188,699
+48,199
| +34% | +$167K | ﹤0.01% | 4448 |
|
|
2019
Q1 | $514K | Sell |
140,500
-7,000
| -5% | -$25.5K | ﹤0.01% | 4529 |
|
|
2018
Q4 | $509K | Sell |
147,500
-5,509
| -4% | -$19K | ﹤0.01% | 4770 |
|
|
2018
Q3 | $528K | Sell |
153,009
-6,991
| -4% | -$24.6K | ﹤0.01% | 4973 |
|
|
2018
Q2 | $591K | Buy |
160,000
+25,500
| +19% | +$101K | ﹤0.01% | 4989 |
|
|
2018
Q1 | $610K | Buy |
134,500
+1,500
| +1% | +$6.73K | ﹤0.01% | 4883 |
|
|
2017
Q4 | $544K | Buy |
133,000
+7,374
| +6% | +$31K | ﹤0.01% | 4931 |
|
|
2017
Q3 | $601K | Sell |
125,626
-2,700
| -2% | -$13K | ﹤0.01% | 4760 |
|
|
2017
Q2 | $543K | Buy |
128,326
+3,000
| +2% | +$12.8K | ﹤0.01% | 4749 |
|
|
2017
Q1 | $597K | Buy |
125,326
+21,695
| +21% | +$99.7K | ﹤0.01% | 4730 |
|
|
2016
Q4 | $397K | Buy |
103,631
+12,326
| +13% | +$50.1K | ﹤0.01% | 5055 |
|
|
2016
Q3 | $400K | Buy |
91,305
+15,700
| +21% | +$76.1K | ﹤0.01% | 4644 |
|
|
2016
Q2 | $332K | Buy |
75,605
+31,577
| +72% | +$149K | ﹤0.01% | 4664 |
|
|
2016
Q1 | $242K | Sell |
44,028
-15,244
| -26% | -$92.4K | ﹤0.01% | 4868 |
|
|
2015
Q4 | $515K | Sell |
59,272
-104,011
| -64% | -$901K | ﹤0.01% | 4525 |
|
|
2015
Q3 | $1.43M | Buy |
163,283
+133,991
| +457% | +$968K | ﹤0.01% | 3812 |
|
|
2015
Q2 | $204K | Sell |
29,292
-6,584
| -18% | -$41.2K | ﹤0.01% | 5220 |
|
|
2015
Q1 | $227K | Sell |
35,876
-70,300
| -66% | -$355K | ﹤0.01% | 5142 |
|
|
2014
Q4 | $452K | Buy |
106,176
+81,945
| +338% | +$364K | ﹤0.01% | 4731 |
|
|
2014
Q3 | $106K | Sell |
24,231
-3,331
| -12% | -$15K | ﹤0.01% | 5461 |
|
|
2014
Q2 | $122K | Buy |
27,562
+626
| +2% | +$2.59K | ﹤0.01% | 5405 |
|
|
2014
Q1 | $123K | Buy |
26,936
+8,481
| +46% | +$40K | ﹤0.01% | 5361 |
|
|
2013
Q4 | $87K | Buy |
+18,455
| New | +$78.3K | ﹤0.01% | 5395 |
|
Morgan Stanley's SMED Position: Q3 2022 in Review
Morgan Stanley sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 452,957 shares — an estimated $1.32M sold.
Morgan Stanley first reported a position in SMED in Q4 2013 and held it in 35 quarters. The position peaked at $6.21M in Q2 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.
- Morgan Stanley reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
- Morgan Stanley sold 452,957 Sharps Compliance Corp shares in Q3 2022, an estimated $1.32M.
- Morgan Stanley first reported a position in Sharps Compliance Corp in Q4 2013 and held it in 35 quarters.
- Morgan Stanley's Sharps Compliance Corp position peaked at $6.21M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.